Your Article Summary
See Latest Articles A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity
Annals of Oncology, 03/27/08
Tol J et al. – For first-line treatment of advanced colorectal cancer (ACC), cetuximab addition to capecitabine, oxaliplatin and bevacizumab is safe and feasible with no observed excessive or unexpected toxicity in the cetuximab treatment arm
Methods- Study to evaluate the effect of adding cetuximab to capecitabine, oxaliplatin and bevacizumab in first-line treatment of ACC (CAIRO2 study)
- Randomization of 755 pts to treatment with capecitabine, oxaliplatin and bevacizumab with or without cetuximab
- Primary end point: progression-free survival
- Toxicity results for first 400 pts reported
- Incidence of overall grade 3–4 toxicity was significantly higher in arm B (81%) vs arm A (72%)
- Toxicity difference is fully attributed to cetuximab-related skin toxicity
- Addition of cetuximab did not increase gastrointestinal toxicity or treatment-related mortality
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
Distinct features of colorectal cancer in children and adolescents
Cancer, 12/15/09
Position Statement: Nonanesthesiologist Administration of Propofol for GI Endoscopy
Gastroenterology, 12/15/09
Colorectal cancer: incidence and trend in Brunei Darussalam
Singapore Medical Journal, 12/15/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
Cost Effectiveness and Resource Allocation, 12/15/09
Medication Usage and the Risk of Neoplasia in Patients With Barretts Esophagus
Clinical Gastroenterology and Hepatology , 12/15/09
Spontaneous bacterial peritonitis: Few additional points
World Journal of Gastroenterology, 12/15/09